Roswell Park Spinoff Company Advances Toward New Clinical Trial for...

The inventors of a new and unique cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, SurVaxM — a multimillion-dollar...(PRWeb November 21, 2019)Read the full story at https://www.prweb.com/releases/roswell_park_spinoff_company_advances_toward_new_clinical_trial_for_brain_cancer_immunotherapy_survaxm/prweb16737735.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news